Company / PP&E (Net)
AYTU BIOPHARMA, INC PP&E (Net) History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$532.0K
FY2025
5-year range
$532.0K / $1.8M
FY2021-FY2025
Trend
-23.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
PP&E (Net) has fluctuated over the past 8 years, ranging from $29,706 in FY2015 to $2M in FY2023.
Based on SEC 10-K filings.
$532,000 in FY2025 with a 10-year CAGR of +33.4%.
Declined from $2M to $532,000 over the past 2 years.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +15.5%
- 10-Year CAGR
- +33.4%
Key checks
Key Insights
- 5-year CAGR of +15.5%, indicating consistent growth.
- In FY2025, pp&e (net) decreased 23.2% year-over-year.
- Peak pp&e (net) was recorded in FY2023.
- Lowest pp&e (net) in the period was in FY2015.
Company context
Key Data Points
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $532.0K | -23.2% |
| FY2024 | $693.0K | -61.8% |
| FY2023 | $1.8M | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | $258.5K | +18.2% |
| FY2018 | $218.7K | -66.2% |
| FY2017 | $647.3K | +179.7% |
| FY2016 | $231.4K | +679.1% |
| FY2015 | $29.7K | +295.1% |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026